Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment

Omitting contralateral SBx in patients with unilateral MRI lesions had limited effect on grading, risk classification, and LNI estimates. However, ipsilateral SBx adds significant diagnostic value compared with TBx alone and should be retained. These findings support a more targeted diagnostic approach in patients with a unilateral lesion on MRI in a primary diagnostic setting.

Authors

Institutions

Publication Details

Journal
BJUI Compass
Published
2026-02-01
DOI
https://doi.org/10.1002/bco2.70154
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment

Ivo G. Schoots, J.O.R.G. Oddens, André N. Vis, Sylvia Bösch et al.
BJUI Compass
Prostate Cancer Diagnosis and Treatment
article

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment

Ivo G. Schoots, J.O.R.G. Oddens, André N. Vis, Sylvia Bösch, Katelijne C. C. de Bie, Arnoud W. Postema, Auke Jager, Daniël L. van den Kroonenberg, Bram W. van Bruggen, Daniela E. Oprea‐Lager
article en

Abstract

Omitting contralateral SBx in patients with unilateral MRI lesions had limited effect on grading, risk classification, and LNI estimates. However, ipsilateral SBx adds significant diagnostic value compared with TBx alone and should be retained. These findings support a more targeted diagnostic approach in patients with a unilateral lesion on MRI in a primary diagnostic setting.

BJUI CompassVol. 7(2)
Radboud University Nijmegen (NL), Leiden University Medical Center (NL), Erasmus MC (NL), Radboud University Medical Center (NL), Amsterdam Neuroscience (NL), Amsterdam University Medical Centers (NL), Erasmus University Rotterdam (NL)
Good health and well-being
Openalex Percentile: Top 69%
Prostate Cancer Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.